Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.640
-0.100 (-5.75%)
At close: Mar 5, 2026, 4:00 PM EST
1.680
+0.040 (2.44%)
After-hours: Mar 5, 2026, 7:58 PM EST
Palisade Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Palisade Bio stock have an average target of 13, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 692.68% from the current stock price of 1.64.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palisade Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 4 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +204.88% | Feb 25, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +326.83% | Jan 9, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +631.71% | Dec 30, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $25 | Buy | Initiates | $25 | +1,424.39% | Dec 29, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +875.61% | May 13, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.78
from -10.19
EPS Next Year
-0.39
from -0.78
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.19 | -0.17 | ||||
| Avg | -0.78 | -0.39 | ||||
| Low | -1.80 | -1.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.